Legend Biotech

1. Legend Biotech corporate update2026Legend Biotech corporate update, 2026, routine
2. LB2501 interim2H 2026LB2501 interim, 2H 2026, notable
3. TaVec in vivo platform filing2H 2026TaVec in vivo platform filing, 2H 2026, notable
4. anito-cel Arcellx PDUFA dateDec 23, 2026anito-cel Arcellx PDUFA date, Dec 23, 2026, thesis-defining
5. Janssen Funding Advance corporate update1Q 2027Janssen Funding Advance corporate update, 1Q 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.